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Abstract Epidermal growth factor receptor (EGFR)
interacting with Stat3 is considered to be an attractive
therapeutic target. In the current study, we investigated
the effect of resveratrol and its two 40-methylthio-trans-
stilbene derivatives (3-M-40-MTS; S2) (3,5-DM-400-MTS;
S5) on EGFR and Stat3 activation in human immortal-
ized HaCaT keratinocytes and epidermoid carcinoma
A431 cells. In the HaCaT cells both derivatives, simi-
larly as resveratrol, decreased the total level of the
EGFR receptor. In the A431 cells, resveratrol in the
higher dose significantly (p \ 0.05) reduced Y1173 and
Y1068 EGFR residue phosphorylation, while S2 affected
only the phosphorylation of the Y1068 residue. In this
cell line, resveratrol in both tested doses and the S2
derivative in the lower concentration significantly
diminished Stat3 binding capacity to the DNA consensus
site. The effect of the tested compounds on Stat3 acti-
vation in HaCaT cells was only slightly affected. These
results indicate that methylthiostilbenes are not more
potent modulators of the EGFR/Stat3 complex than res-
veratrol and that introducing an additional methoxy
group makes them less effective.
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Abbreviations
A431 Human epidermoid carcinoma cells
DMEM Dulbecco’s Modified Eagle’s Medium
DMSO Dimethyl sulfoxide
EGFR Epidermal growth factor receptor
FBS Fetal bovine serum
HaCaT Spontaneously immortalized human
keratinocytes






Stat Signal transducer and activator of transcription
Introduction
Keratinocytes are not only primary sensors of stressful
conditions, but also major players of the extremely com-
plex response in the skin when conducting the orchestrated
recruitment and functions of the immune cells, fibroblasts,
and vascular cells which are involved in inflammatory
responses and wound healing. The epidermal growth factor
receptor (EGFR), located on the cellular membrane of the
keratinocytes, is widely recognized as a key regulator of
numerous essential processes underlying skin development,
homeostasis, and repair [1]. EGFR is a 170-kDa glyco-
protein that consists of an extracellular receptor domain, a
trans-membrane region, and an intracellular domain with
tyrosine kinase function [2]. EGFR is expressed through all
layers of the human epidermis, with the strongest presence
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in the basal layer of the epidermal keratinocytes. Several
lines of evidence indicate the existence of two modes of
EGFR signaling. The traditional cytoplasmic EGFR route
involves transduction of mitogenic signals through the
activation of numerous signaling cascades, signal trans-
ducers, and activators of transcription (Stats). In the
nuclear pathway, activated EGFR undergoes direct nuclear
translocation, where it interacts with other transcription
factors possessing DNA-binding activity, including (Stat3),
which leads to up-regulation of distinct genes controlling
cell proliferation and DNA repair [3]. Stat3 is a cytoplas-
mic protein that is activated in response to cytokines and
growth factors and is considered as molecular machinery
that regulates cell fate determination, renewal, differenti-
ation, and apoptosis of various cell types, especially that
ones at the embryonic developing stages [4, 5]. On acti-
vation, Stat3 molecules are translocated to nucleus, where
they activate transcription of a series of target genes
including c-Myc, survivin, and cyclin D1 that are closely
associated with the growth, survival, and progression of
cancer cells [5]. Indeed, in cancerous cells Stat3 constitu-
tive activation is common, which is likely due to the
aberrant activity of Stat3’s upstream signaling pathways,
such as, EGFR, HER2, Src, and JAK2. Tumorigenic Stat3
activation has been frequently linked to more malignant
cancer behaviors, including growth, epithelial-mesenchy-
mal transition, migration, invasion, and metastasis. Stat3
activation is also associated with tumor survival and ther-
apeutic resistance [6]. Many studies also have confirmed,
the importance of Stat3 in skin carcinogenesis, skin cancer
prevention, and treatment [4].
There is steadily growing interest in skin protection by
plant polyphenols, although the mechanisms by which
these natural compounds exert their beneficial effects are
not fully understood [7]. One such polyphenol is resvera-
trol (3,5,40-trihydroxy-trans-stilbene), a naturally occurring
phytoalexin and the most extensively studied stilbene
derivative. This compound has been shown to exert several
beneficial effects, including cancer chemopreventive
activity, in several preclinical studies [8, 9].
However, an important issue connected with the future
application of resveratrol in disease management is its low
bioavailability due to its rapid metabolism in mammals
[10]. A strategy targeted at discovering and defining novel
analogs of resveratrol has been assumed. These analogs
should have the same structural backbone of resveratrol,
with chemical modifications resulting in superior efficacy
[11].
Our earlier studies showed that introduction of the
methylthio-group into the stilbene core may influence the
efficacy and selectivity of the inhibitory potency of these
compounds toward the P450 isozymes, CYP1A1 and 1B1
[12, 13]. Other authors showed that substitution of the 40
oxygen atom with a less electronegative sulfur atom also
reduced toxicity toward the HEK 293 cells and enhanced
the compound’s ability to activate human SIRT1 [14].
The aim of the present study was to further explore the
activity of resveratrol and its methylthio-derivatives by
evaluating their effect on EGFR and Stat3 activation. Two
40-methylthio-trans-stilbene derivatives possessing one (3-
M-40-MTS; S2) and two (3,5-DM-40-MTS; S5) methoxy
groups were assessed, and immortalized human HaCaT
keratinocytes and human epidermoid carcinoma A431 cells




Resveratrol (purity 99 %), dithiothreitol, antibiotic solution
(104 U penicillin, 10 mg streptomycin, 25 lg amphotericin
B), bovine serum albumin (BSA), dimethyl sulfoxide
(DMSO), fetal bovine serum (FBS), Dulbecco’s Modified
Eagle’s Medium (DMEM), and Tris were purchased from
Sigma Chemicals (St. Louis, MO, USA). Primary and
secondary antibodies against EGFR, Y1173-EGFR,
Y1068-EGFR, Stat3, c-Myc, Bcl-xL, and b-actin were
supplied by Santa Cruz Biotechnology (Santa Cruz, CA,
USA). SDS-PAGE Gels (7.5 %, 10 %, 12 %) and the
Western blotting detection system were purchased from
Bio-Rad Laboratories (Hercules, CA, USA). All other
compounds were readily available commercial products.
3-methoxy-40-methylthio-trans-stilbene (S2) and 3,5-
dimethoxy-40-methylthio-trans-stilbene (S5) were synthe-
sized as described previously [12]. Their structures are
shown in Fig. 1.
Cell culture and treatment
Spontaneously immortalized human keratinocyte HaCaT
cells, purchased from Cell Lines Service (CLS, Germany),
and human epidermoid carcinoma A431 cells, obtained
from Deutsche Sammlung von Mikroorganismen und
Zellkulturen (DSMZ, Germany), were grown in DMEM
containing 10 % FBS supplemented with antibiotics (pen-
icillin, streptomycin, and amphotericin B). The cells were
incubated at 37 C in an atmosphere consisting of 95 % air
and 5 % CO2 in a humidified incubator until they reached
80 % confluency. 1 9 106 cells were seeded in 100 mm ø
culture dishes. After 24 h of preincubation in DMEM
containing 5 % of FBS, the cells were treated with either
20 and 60 lM resveratrol, 20 and 60 lM S2 derivative, 5
and 20 lM S5 compound, or 0.1 % DMSO (control cells).
Incubation was continued for a subsequent 24 h, then the
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cells were harvested. The preliminary experiments were
performed in which the effect of resveratrol and its deriv-
atives on EGFR at different time points (2, 4, 12, and 24 h)
was estimated. No significant differences in time-course
response were observed. For this reason, only one time
point of 24 h was chosen for further studies.
Cell viability assay
The effects of resveratrol and methylthiostilbenes on cell
viability were assessed with MTT assay according to
standard protocols. Since the data on cytotoxicity of these
compounds in HaCaT cells were presented previously [15],
the MTT test was performed only in A431 cells. Briefly,
104 cells were seeded per well in a 96-well plate. After 24 h
of preincubation in DMEM containing 5 % FBS, the tested
compounds were added to the culture medium in various
concentrations (0–200 lM), and the cells were incubated
for a subsequent 72 h. The DMSO concentration did not
exceed 0.1 %. After 72 h, the cells were washed twice with
PBS buffer, and a fresh medium containing MTT salt
(0.5 mg/ml) was added. After 4 h of incubation, formazan
crystals were dissolved in acidic isopropanol and absor-
bance was measured at 540 and 690 nm. All of the
experiments were repeated three times, with at least three
measurements per assay.
In all of the subsequent experiments, non-toxic con-
centrations of methylthiostilbenes and resveratrol (viability
level above 70 %) were used ranging from 5 to 60 lM,
depending on compound.
Cell fractionation
Cytosol and nuclear extracts from HaCaT and A431 cells
were prepared using the Nuclear/Cytosol Fractionation Kit
(Active Motif, Carlsbad CA, USA). Whole cell lysates
were prepared from HaCaT and A431 cells using the
standard RIPA buffer.
Western blot analysis
Immunoblot assay was used to determine the level of
EGFR, Y-1173-EGFR, Y-1068-EGFR Stat3, c-Myc, and
Bcl-xL proteins. The protein content in the samples was
determined with the Lowry method. Whole cell lysates
(EGFR, Y-1173-EGFR, Y-1068-EGFR, c-Myc, Bcl-xL),
nuclear and cytosolic fraction (Stat3) (50–100 lg) were
separated on 10 % or 7.5 % or 12 % SDS-PAGE gels, and
the proteins were transferred to nitrocellulose membranes
[16, 17]. After blocking with 10 % skimmed milk, the
proteins were probed with rabbit polyclonal EGFR, rabbit
polyclonal Y-1173-EGFR, goat polyclonal Y-1068-EGFR,
rabbit polyclonal Stat3, mouse monoclonal c-Myc, mouse
monoclonal Bcl-xL, and rabbit polyclonal b-actin anti-
bodies. The b-actin protein was used as an internal control.
Alkaline phosphatase-labeled anti-rabbit IgG, anti-mouse
IgG, or anti-goat IgG were used as the secondary anti-
bodies in the staining reaction. The amount of immunore-
active product in each lane was determined using Quantity
One software (BioRad Laboratories, Hercules, CA, USA).
Values were calculated as relative absorbance units (RQ)
per mg of protein.
Stat3—DNA-binding assay
Stat3 activation was assessed by estimating Stat3—DNA-
binding capacity assay by the means of enzymatic immu-
noassay according to Jin et al. [18] using commercial kits
(TransAM Stat Family; Active Motif, Carlsbad CA, USA)
and following the manufacturer’s instructions. The
amounts of Stat3 protein contained in DNA-binding com-
plex were measured, and the Stat consensus binding site
(50-TTCCCGGAA-30) was immobilized on ELISA micro-
plates as a bait. The results were expressed as absorbance
(OD450nm) per mg of protein.
Statistical analysis
The statistical analysis was performed by one-way
ANOVA. The statistical significance between the experi-
mental groups and their respective controls was assessed by
Tukey’s post hoc test, with p \ 0.05 being considered
significant.
Fig. 1 Structures of resveratrol and methylthiostilbenes
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Results
The effect of resveratrol and methylthiostilbenes on cell
viability in A431 cells
Figure 2 presents data on the effect of stilbenes on A431
viability. Within the concentration range of 2–200 lM, the
tested compounds reduced the viability of the A431 cells in
a dose-dependent manner. In this cell line, cytotoxicity of
S5 was similar to the effect of resveratrol and compound
S2 was less toxic. However, compound S2 exhibited higher
toxicity toward A431 cells in comparison with HaCaT cells
(IC50 182.66 ± 38.71 vs 141.28 ± 2.80 lM). Resveratrol
also displayed higher toxicity toward A431 cells than to
HaCaT cells (IC50 85.23 ± 29.17 vs 49.44 ± 3.76 lM),
while the toxicity of S5 was similar in both cell lines [15].
The effect of resveratrol and methylthiostilbenes
on EGFR activation in HaCaT and A431 cells
The effects of resveratrol and methylthiostilbenes on both
the EGFR protein level and activation are shown in Fig. 3.
In the HaCaT cells both derivatives, similarly to resvera-
trol, decreased the total level of the EGFR protein but did
not affect the level of the phosphorylated Y1173 or Y1068
forms of this receptor (Fig. 3a). A different effect was
observed in the A431 cells (Fig. 3b), where none of the
compounds affected the total level of the EGFR protein,
but the level of EGFR phosphorylation of the Y1068 res-
idue was significantly (p \ 0.05) reduced by resveratrol in
the higher dose and by S2 in both doses. Additionally,
resveratrol in the higher dose (60 lM) significantly
diminished the level of Y1173 phosphorylation.
The effect of resveratrol and methylthiostilbenes
on Stat3 activation in HaCaT and A431 cells
Figures 4 and 5 show the effect of resveratrol and meth-
ylthiostilbenes on Stat3 activation, estimated in terms of
Fig. 2 Effect of resveratrol (RES) and methylthiostilbenes (S2, S5)
on the viability of A431 cells. The mean values ± SEM from three
independent experiments run in triplicate are shown. The viability of
vehicle-treated cells was considered 100 %
Fig. 3 Effect of resveratrol and
methylthiostilbenes on EGFR
activation in HaCaT (a) and
A431 (b) cells. Levels of the
protein were assessed by
Western blot analysis.
Representative immunoblots
and data (mean ± SEM) from
three independent experiments
run in duplicate are presented.
b-actin was used as an internal
control. The asterisk above the
bar denotes statistically
significant differences from the
control cells (DMSO), p \ 0.05
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translocation of the Stat3 protein from the cytosol to the
nuclear fraction (Fig. 4), and measured by Western blot
and the binding capacity to DNA consensus sequences
(Fig. 5). None of the tested compounds changed the level
of Stat3 in the cytosolic or nuclear fractions of the HaCaT
cells (Fig. 4a). However, resveratrol in the higher dose, and
S2 in both doses, significantly increased Stat3 binding
capacity to the DNA consensus site (Fig. 5a) in these cells.
The S5 derivative had just the opposite effect, as in both of
the tested doses this compound significantly diminished
Stat3-DNA binding by approximately 50 %.
In human epidermoid carcinoma A431 cells, resveratrol
was the only compound affecting the total level of the Stat3
protein, as it significantly diminished this transcription
factor content in the nuclear fraction by 20 % (Fig. 4b).
Also, resveratrol significantly diminished the Stat3 binding
capacity to the Stat consensus sequence in a dose-depen-
dent manner (Fig. 5b), while S2 was active to a much
lesser extent and only in the lower concentration. In the
case of S5, which significantly affected Stat3 binding in the
HaCaT cells, no statistically significant effect was observed
in human skin carcinoma A431 cells.
Fig. 4 Effect of resveratrol and
methylthiostilbenes on Stat3
translocation in HaCaT (a) and
A431 (b) cells assayed by
Western blot analysis.
Representative immunoblots
and data (mean ± SEM) from
three independent experiments
run in duplicate are presented.
b-actin was used as an internal
control. The asterisk above the
bar denotes statistically
significant differences from the
control cells (DMSO), p \ 0.05
Fig. 5 Effect of resveratrol and methylthiostilbenes on Stat3 activa-
tion in HaCaT (a) and A431 (b) cells. Activated Stat3 was assessed in
terms of the amount of Stat3 contained in the DNA-binding
complexes extracted from the nuclei that were isolated from the
cells. The Stat consensus site (50-TTCCCGGAA-30) was immobilized
on ELISA plates as bait. Bars represent mean ± SEM from three
independent experiments run in duplicate. The asterisk above the bar
denotes statistically significant differences from the control cells
(DMSO), p \ 0.05
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The effect of resveratrol and methylthiostilbenes
on Stat3 downstream targeted genes in HaCaT
and A431 cells
Figure 6 shows the effect of resveratrol and methylthio-
stilbenes on c-Myc and Bcl-xL protein level in A431 cells.
In these cells, only resveratrol in the higher dose (60 lM)
significantly diminished the level of c-Myc. The level of
these proteins in HaCaT cells was too low for quantitative
statistical evaluation.
Discussion
Overexpression and/or increased activity of EGFR are the
key characteristics of human tumors and are frequently
linked to more aggressive tumor behavior, including
increased proliferation, metastasis, and therapeutic resis-
tance [19].
Several reports described the nuclear localization of
EGFR which resulted from translocation directly into the
nucleus and which omitted the traditional pathway that
requires the activation of signaling cascades [20, 21].
Although EGFR possesses transactivational activity, it
lacks a DNA-binding domain and requires a DNA-binding
transcription cofactor for its transcriptional function. In this
regard, it was shown that EGFR physically and function-
ally interacts with Stat3 in the nucleus, leading to tran-
scriptional activation of the inducible nitric oxide synthase
(iNOS) gene. Thus, combining agents targeting both EGRF
and Stat3 may improve the chemopreventive and/or ther-
apeutic effect. Indeed, the combination of AG490 and
AG1478 was more potent than the inhibitor alone in killing
EGFR-overexpressing cells, i.e., A431 and MDA-MB-468
(human breast carcinoma) [22]. Single agents affecting
both of these targets are equally desired.
Resveratrol has been demonstrated to affect a multitude
of signal transduction pathways associated with tumori-
genesis [23]. In mouse skin, reduction of the iNOS protein
level and activity elevated by the tumor promoter, TPA,
were observed as a result of pretreatment with resveratrol,
and even more by its naturally occurring analog,
pterostilbene.
This observation may imply the involvement of altered
EGFR/Stat3 activation in TPA induction of iNOS in mouse
skin. Moreover, it suggests that resveratrol analogs might
be more efficient in the modulation of this pathway.
In this study, we compared the effect of resveratrol and
its methylthio-derivatives on the expression and activation
of EGFR and Stat3 in two cell lines which differed in
EGFR expression. While the A431 cells were characterized
by EGFR-overexpression, spontaneously immortalized
keratinocytes, HaCaT cells, have low constitutive EGFR
activity. Moreover, EGFR activation in HaCaT cells had no
effect on Stat3 Y705 phosphorylation [24] .
Activation of EGFR results in autophosphorylation of
the C-terminal region. The major sites of phosphorylation
are the Y1068 and Y1173 tyrosine residues [25].
Treatment of the HaCaT cells with either resveratrol or
methylthiostilbenes did not affect the phosphorylation of
these residues, although the total level of the EGFR protein
was significantly reduced. This may suggest that stilbenes
might reduce the constitutive expression of EGFR or
stimulate its degradation. The latter may occur e.g.,
through activating of ubiquitination and sorting machinery
such as ESCRT [26]. It also cannot be excluded that other
EGFR residues which were not evaluated in this study
might be affected and contributed to overall EGFR protein
reduction. The possible candidates are 1045 and 1173
tyrosine residues which were found to be phosphorylated in
A431 cells, but were not evaluated yet in HaCaT cells [27].
In EGFR-overexpressing A431 cells, a significant
reduction of EGFR with both phosphorylated residues was
observed as a result of resveratrol at higher dose treatment.
Compound S2, 3-methoxy-40-methylthio-trans-stilbene,
significantly reduced the level of EGFR with the
Fig. 6 Effect of resveratrol and methylthiostilbenes on Stat3 down-
stream targeted genes in A431 cells assayed by Western blot analysis.
Representative immunoblots and data (mean ± SEM) from three
independent experiments run in duplicate are presented. b-actin was
used as an internal control. The asterisk above the bar denotes
statistically significant differences from the control cells (DMSO),
p \ 0.05
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phosphorylated Y1068 tyrosine residues. Introducing an
additional methoxy group to the stilbene ring made this
compound ineffective as an EGFR activation modulator.
Reducing the phosphorylation of the Y1068 residue by
resveratrol and compound S2 may have further conse-
quences, as we found in our previous studies that phos-
phorylation of this tyrosine correlated with AP-1 activation
in mouse skin. This transcription factor is involved in
COX-2 and iNOS induction, which is reduced by resve-
ratrol in this model [28, 29].
Reduced activation of EGFR by resveratrol and its S2
analog was connected with reduced activation of Stat3.
Resveratrol treatment reduced the binding level of this
transcription factor to its consensus oligonucleotide mea-
sured in terms of its amount in the DNA-binding complex
extracted from the nuclear fraction of the A431 cells. Thus
this observation indirectly confirmed the interaction of
EGFR and Stat3 in these cells, as was described by Lo et al.
[30].
On the other hand, in the HaCaT cells the S5 stilbenoid
reduced the binding of Stat3 to its consensus sequence,
while resveratrol and the S2 compound increased Stat3
activation. The above-mentioned studies by Quadros et al.
[24] demonstrated, however, that DNA binding of activated
Stat3 is restricted to malignant cells (SCC) and strictly
dependent on EGFR activation. Thus the results of our
current experiments may suggest that activation of Stat3 in
nonmalignant cells, such as HaCaT, in response to stilbene
treatment occurs in an EGFR-independent way. Further
studies are required to confirm this suggestion. Collec-
tively, the results of our present study indicate that stilbe-
noids may affect both EGFR and Stat3 in malignant,
EGFR-overexpressing tumor cells.
However, modification of the stilbene ring does not
affect the EGFR/Stat3 system to a greater extent than
resveratrol.
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